Gut microbiome: a key driver and therapeutic target of intestinal fibrosis in Crohn’s disease
Intestinal Research · 10.08.2026
DOI: 10.5217/ir.2026.00013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Intestinal Research, online erschienen am 10.08.2026. Verfasst von Jee Hyun Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul …. Die Arbeit nennt 142 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
- Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
- Institute of Basic Medical Sciences, CHA University School of Medicine, Seongnam, Korea.
- Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Korea. jhyoo@cha.ac.kr.
- Institute of Basic Medical Sciences, CHA University School of Medicine, Seongnam, Korea. jhyoo@cha.ac.kr.
Zitieren
APA
Kim, J. H., Choi, Y. J., & Yoo, J. H. (2026). Gut microbiome: a key driver and therapeutic target of intestinal fibrosis in Crohn’s disease. Intestinal Research. https://doi.org/10.5217/ir.2026.00013
Vancouver
Kim JH, Choi YJ, Yoo JH. Gut microbiome: a key driver and therapeutic target of intestinal fibrosis in Crohn’s disease. Intestinal Research. 2026. doi:10.5217/ir.2026.00013
BibTeX
@article{Kim2026,
author = {Kim, Jee Hyun and Choi, Yoon Jeong and Yoo, Jun Hwan},
title = {Gut microbiome: a key driver and therapeutic target of intestinal fibrosis in Crohn’s disease},
journal = {Intestinal Research},
year = {2026},
doi = {10.5217/ir.2026.00013}
}
EUVIMED